December 27, 2021
The Ministry of Health, Labor and Welfare (MHLW) has decided that it will not recommend Chugai Pharmaceutical’s COVID-19 antibody cocktail Ronapreve (casirivimab + imdevimab) for people infected with the Omicron variant following data suggesting its diminished potency against the new...read more